BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17264034)

  • 21. Candida dubliniensis: ten years on.
    Sullivan DJ; Moran GP; Coleman DC
    FEMS Microbiol Lett; 2005 Dec; 253(1):9-17. PubMed ID: 16213674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina.
    Luque AG; Biasoli MS; Tosello ME; Binolfi A; Lupo S; Magaró HM
    Mycoses; 2009 Jan; 52(1):53-9. PubMed ID: 18498298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incubation at room temperature may be an independent factor that induces chlamydospore production in Candida dubliniensis.
    Sancak B; Colakoglu S; Acikgoz ZC; Arikan S
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):305-9. PubMed ID: 16054328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina.
    Jewtuchowicz VM; Mujica MT; Brusca MI; Sordelli N; Malzone MC; Pola SJ; Iovannitti CA; Rosa AC
    Oral Microbiol Immunol; 2008 Dec; 23(6):505-9. PubMed ID: 18954358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of 5 new media containing extracts of seeds applied to Candida dubliniensis screening.
    Loreto ES; Bolzan AR; Linares CE; Boff E; Santurio JM; Alves SH
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):191-3. PubMed ID: 16545931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial Candida dubliniensis isolate in Candida spp. positive haemocultures in Turkey between 2001 and 2004.
    Tekeli A; Akan OA; Koyuncu E; Dolapci I; Uysal S
    Mycoses; 2006 Jan; 49(1):60-4. PubMed ID: 16367821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of Candida dubliniensis in denture stomatitis.
    Marcos-Arias C; Vicente JL; Sahand IH; Eguia A; De-Juan A; Madariaga L; Aguirre JM; Eraso E; Quindós G
    Arch Oral Biol; 2009 Feb; 54(2):127-31. PubMed ID: 18950745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Candida dubliniensis fungemia in Argentina: identification by a novel multiplex PCR and comparison of different phenotypic methods.
    Bosco-Borgeat ME; Taverna CG; Cordoba S; Isla MG; Murisengo OA; Szusz W; Vivot W; Davel G
    Mycopathologia; 2011 Nov; 172(5):407-14. PubMed ID: 21750939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast.
    Savini V; Catavitello C; Onofrillo D; Masciarelli G; Astolfi D; Balbinot A; Febbo F; D'Amario C; D'Antonio D
    Mycoses; 2011 Sep; 54(5):434-41. PubMed ID: 21039941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First isolations in India of Candida nivariensis, a globally emerging opportunistic pathogen.
    Chowdhary A; Randhawa HS; Khan ZU; Ahmad S; Juneja S; Sharma B; Roy P; Sundar G; Joseph L
    Med Mycol; 2010 Mar; 48(2):416-20. PubMed ID: 19626545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Candida dubliniensis: first identification in Sfax Hospital, Tunisia.
    Khlif M; Sellami H; Sellami A; Chelly H; Makni F; Bouaziz M; Ayadi A
    Mycoses; 2009 Mar; 52(2):171-5. PubMed ID: 18522698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid identification of Candida albicans and its related species Candida stellatoidea and Candida dubliniensis by a single PCR amplification using primers specific for the repetitive sequence (RPS) of Candida albicans.
    Kanbe T; Kurimoto K; Hattori H; Iwata T; Kikuchi A
    J Dermatol Sci; 2005 Oct; 40(1):43-50. PubMed ID: 16054340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of antifungal drug resistance in Candida dubliniensis.
    Coleman DC; Moran GP; McManus BA; Sullivan DJ
    Future Microbiol; 2010 Jun; 5(6):935-49. PubMed ID: 20521937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans.
    Pinjon E; Sullivan D; Salkin I; Shanley D; Coleman D
    J Clin Microbiol; 1998 Jul; 36(7):2093-5. PubMed ID: 9650971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
    Chen SC; Marriott D; Playford EG; Nguyen Q; Ellis D; Meyer W; Sorrell TC; Slavin M;
    Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging fungal resistance.
    Baddley JW; Moser SA
    Clin Lab Med; 2004 Sep; 24(3):721-35, vii. PubMed ID: 15325062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of nine atypical Candida dubliniensis clinical isolates.
    Albaina O; Sahand IH; Brusca MI; Sullivan DJ; Fernández de Larrinoa I; Moragues MD
    J Med Microbiol; 2015 Feb; 64(Pt 2):147-156. PubMed ID: 25480879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An update on Candida dubliniensis].
    Paugam A; Baixench MT; Viguié C
    Med Mal Infect; 2008 Jan; 38(1):1-7. PubMed ID: 18065177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chlamydospore formation in Candida albicans and Candida dubliniensis--an enigmatic developmental programme.
    Staib P; Morschhäuser J
    Mycoses; 2007 Jan; 50(1):1-12. PubMed ID: 17302741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.